Mouse embryonic chimeras are a well-established tool for studying cell lineage commitment and pluripotency. Experimental chimeras were successfully produced by combining two or more preimplantation embryos or by introducing into host embryo cultured pluripotent embryonic stem cells (ESCs). Chimera production using genetically modified ESCs became the method of choice for the generation of knockout or knockin mice. Although the derivation of ESCs or ESC-like cells has been reported for other species, only mouse and rat pluripotent stem cells have been shown to contribute to germline-competent chimeras, which is the defining feature of ESCs. Herein, we describe different approaches employed for the generation of embryonic chimeras, define chimera-competent cell types, and describe cases of spontaneous chimerism in humans. We also review the current state of derivation of pluripotent stem cells in several species and discuss outcomes of various chimera studies when such cells are used.
Developmental potential and embryonic chimerism
The term 'chimerism' is derived from the Greek Xímaira, meaning 'she-goat or monster', a monstrous fire-breathing creature composed of the parts of three animals: a lion, a serpent, and a goat. In biology, the term 'chimera' usually refers to a single organism composed of two or more different populations of genetically distinct cells originated from different zygotes. Typically, experimental embryonic chimeras are formed by the aggregation of two or more whole early cleaving embryos or by combining isolated blastomeres from two or more embryos. The contribution level of each parental cell type in the tissues and organs of chimeric offspring can vary. For example, a chimeric organism could potentially consist of an equal mixture of parental embryonic cells in all cell and tissue types or contain only a limited contribution of one of the genotypes in some tissues (microchimerism (Mc)).
The level of contribution in embryonic chimeras largely depends on the developmental potency of parental cells. Mammalian development originates from a state of totipotency, an attribute of zygotes and early cleaving blastomeres. Totipotency is defined as the ability of a single cell to divide and produce all the differentiated cells of an organism including extraembryonic (placental) and embryonic tissues (embryo proper) (Mitalipov & Wolf 2009 ). As development advances, totipotent cells undergo differentiation and segregation into developmentally more restricted cell lineages. The first visual differentiation of an embryo takes place during the formation of a blastocyst, a stage consisting of two cell lineages: the inner cell mass (ICM) and the trophectoderm (TE). The ICM further segregates into the epiblast and primitive endoderm (PE), which subsequently form the embryo proper and parts of the yolk sac respectively. The TE contributes to the extraembryonic tissues including primary and secondary giant cells, spongiotrophoblast, and chorionic ectoderm. The epiblast and its in vitro counterparts, embryonic stem cells (ESCs), are termed pluripotent based on their ability to give rise to all three germ layers (ectoderm, mesoderm, and endoderm) of the embryo proper. However, the epiblast and ESCs also contribute to some extraembryonic tissues (Beddington & Robertson 1989) . Early studies have demonstrated that in addition to the embryo proper, mouse ESCs contribute to the amnion and the extraembryonic mesoderm of allantois, chorion, and yolk sac. Since this phenomenon has not been thoroughly investigated, it could be one of the defining factors responsible for chimera competency of ESCs. It is also important to note that developmental potential of ESCs is more restricted than that of whole ICMs (Rossant & Lis 1979) . As previously stated, it is well documented that in addition to the epiblast lineage, early ICM cells also contribute to the PE that subsequently forms part of the yolk sac. In contrast, ESCs and other pluripotent cell types are not capable of forming the PE and rely on the host embryo complementation for this extraembryonic compartment in chimeras.
The early experimental mouse chimeras were produced in the 1960s by aggregating two or more whole 8-cell embryos resulting in normal-sized mice whose tissues consist of a mixture of parental embryos (Tarkowski 1961 , Mintz 1962 . Chimerism in such embryos extends to the epiblast, the TE, and the PE. Mouse aggregation chimeras have provided an invaluable tool to study important questions in developmental biology, cell lineage commitment, genetics, and immunology (McLaren 1976a , 1976b , Tarkowski 1998 , Alexandre 2001 . Gardner (1968) was able to produce mouse chimeras by an injection of isolated ICM cells into a host blastocyst cavity. Later on, as more mouse chimeric studies were conducted, it became apparent that despite introduction into the 8-cell, morula, or blastocyst host embryos, the ICM contribution was always limited to the epiblast and the PE (Tam & Rossant 2003) . Since the earlier studies were conducted, a range of other pluripotent cell types has been shown to contribute to mouse embryo proper chimeras. Specifically, pluripotent teratocarcinoma cells (Mintz & Illmensee 1975) , ESCs (Bradley et al. 1984) , primordial germ cells (Matsui et al. 1992) , reprogrammed to pluripotency by somatic cell nuclear transfer ESCs (ntESCs; Wakayama et al. 2001) , and induced pluripotent stem cells (iPSCs; Okita et al. 2007) can also contribute to chimeras. The combination of host and donor cell types capable of forming mouse chimeras is illustrated in Fig. 1 .
Mouse chimeras can also be successfully produced with tetraploid host embryos. Experimentally produced tetraploid embryos can be derived by the fusion of mouse 2-cell embryos. Such embryos are not capable of forming viable offspring; however, they have an ability to contribute to functional extraembryonic tissues. When ESCs are introduced into mouse tetraploid embryos, they colonize the embryo proper, the amnion, the allantois, and the mesoderm layer of the yolk sac, while tetraploid cells are restricted to the other remaining extraembryonic tissues resulting in almost completely ESC-derived postnatal offspring (Nagy et al. 1993) . Mutant and wildtype embryos have also been used for aggregation chimeras to pinpoint timing and nature of developmental defects in mutant embryos. The failure or abnormal contribution of defective embryonic cells to a particular lineage, tissue, or organ in chimeras can be complemented and rescued by wild-type embryo cells, thus allowing development to continue (Tam & Rossant 2003) . ESC-tetraploid chimeras can be particularly useful to study defects in the development of extraembryonic lineages. A classical example is the targeted mutation of Hnf4, a gene encoding for the transcription factor known as hepatocyte nuclear factor 4. Homozygous mutant (Hnf4 K/K ) embryos fail to complete gastrulation, resulting in early embryonic arrest (Chen et al. 1994 (Duncan et al. 1997) .
While conventional chimeras are generated by the aggregation of embryos or embryonic cells derived from the same developmental stage, chimeric offspring can be produced by mixing embryonic cells from different developmental stages (Gearhart & Oster-Granite 1981 , Nagashima et al. 2004 ). As pointed above, isolated ICMs can contribute to chimeras not only when injected into the blastocoelic cavity of host blastocysts, but also when introduced into 8-cell-or morula-stage embryos , Polzin et al. 1987 , Roth et al. 1989 , Nagy et al. 1990 , Picard et al. 1990 .
It is critical to utilize genetic, biochemical, or phenotypic markers that would allow to distinguish the contribution of parental cells in a chimeric organism. Aggregation of embryos with a distinct coat color pattern (different strain of mice) has been routinely used as one of the key markers of chimerism during early research studies on chimeras. Other common markers used initially were the electrophoretic variants of the housekeeping enzyme glucose-6-phosphate isomerase (GPI). The major limitation of the GPI is the inability to detect variants at the spatial histological level (Buehr & McLaren 1981 ). An ideal marker would detect a putative chimera at the single-cell level in situ. The first generation of genetic markers that were used to distinguish cells of different origins in chimeras was strain-specific DNA satellite markers (Rossant et al. 1983) . These markers allowed cell lineage tracking based on in situ hybridization of histological samples. At the present time, the most broadly utilized markers are the b-galactosidase enzyme encoded by the Escherichia coli lacZ gene and the green fluorescent protein (GFP). Expression of lacZ can be detected by histochemical staining, while GFP expression detection requires epifluorescent microscopy. Since such transgenes are not readily available for other mammals, additional genetic markers such as microsatellites, also known as short tandem repeats, can be employed (Tachibana et al. 2012 ).
Chimera-competent pluripotent stem cells in the mouse
As discussed, the chimera assay is used as an ultimate pluripotency test for experimentally cultured mouse pluripotent stem cells, such as ESCs and, more recently, iPSCs. While natural pluripotent cells within developing embryos exist transiently, when isolated and explanted using adaptive culture conditions, they can grow in vitro but remain pluripotent. Embryo-derived stem cells termed ESCs can be propagated indefinitely, providing an unlimited source of pluripotent cells. When a few ESCs are reintroduced into a host embryo, they can resume normal developmental program and contribute to all tissues and organs of chimeric offspring. ESCs can be readily isolated using standard techniques, but only from a very few so-called 'permissive' mouse strains (129, C57BL/6, and BALB/c).
Pluripotent cell lines have also been derived from postimplantation mouse epiblasts (days E5.5-7.5) and were termed EpiSCs (Tesar et al. 2007) . Such cells are morphologically distinct from mouse ESCs and also differ based on their growth and culture requirements (Tesar et al. 2007 ). The fundamental distinction from mouse ESCs is that EpiSCs do not contribute to chimeras (Rossant 2008 , Guo et al. 2009 . Speculation is that EpiSCs represent more restricted ('primed') pluripotent cells while ESCs symbolize a developmentally more potent ('naive') state of pluripotency ). The inability of EpiSCs to form chimeras could simply be due to their failure to contribute to the vital extraembryonic tissues. As we have discussed, the epiblast and ESCs colonize the amnion, the allantois as well as the mesoderm layer of the yolk sac. It is conceivable that their initial contribution to the extraembryonic niche is required for subsequent development into the lineages of the embryo proper.
Experimental pluripotent stem cells can also be produced by reprogramming somatic cells. Reprogrammed somatic cells may have a particularly important role in future clinical applications of autologous cell replacement therapies since a patient's own cells would evade host immune-based rejection. Reprogramming of somatic cells to pluripotency can be achieved using two alternative approaches: i) by direct reprogramming into iPSCs or ii) by somatic cell nuclear transfer into ntESCs. Direct reprogramming by current techniques operates by delivering and expressing exogenous genes known to be essential for pluripotency (Takahashi & Yamanaka 2006) . Somatic cell nuclear transfer, often referred to as cloning, is based on oocyte-assisted reprogramming, where the cytoplasm of an enucleated oocyte delivers the essential epigenetic and cytoplasmic factors that support natural reprogramming processes and thus recapitulates the normal development of totipotent and pluripotent cells.
Both mouse ntESCs and iPSCs share the defining feature of embryo-derived ESCs, i.e. their ability to contribute to chimeras (Fig. 2) . In addition, ntESCs and iPSCs have met the current most stringent pluripotency assays and have generated all stem cell-derived mice following tetraploid complementation (Boland et al. 2009 , Lin et al. 2010 . However, when ntESCs and iPSCs were derived from genetically identical donor cells and then compared for their ability to generate mice through tetraploid embryo complementation, only ntESCs resulted in a successful outcome; iPSCs failed to produce whole iPSC mice. This demonstrates that nuclear transfer can generate ESC-equivalent pluripotent stem cells more effectively than factor-based reprogramming (Jiang et al. 2011) . 
Experimental embryonic chimeras in other species
Aggregation of early-cleaving embryos (or isolated blastomeres) have resulted in the birth of chimeric animals in a number of mammals including sheep (Tucker et al. 1974) , rats (Mayer & Fritz 1974) , rabbits (Gardner & Munro 1974) , cattle (Brem et al. 1984) , and, more recently, in nonhuman primates (Tachibana et al. 2012) . Moreover, aggregation of goat and sheep early embryos or injection of goat ICMs into sheep blastocysts can also result in a birth of live interspecies chimeras (Fehilly et al. 1984 , 1985 , Polzin et al. 1987 , Roth et al. 1989 . Chimeric cattle fetuses were produced by the aggregation of embryos generated through somatic cell nuclear transfer with IVF embryos (Stice et al. 1996) . In the rhesus monkey, transplantation of ICMs into blastocysts will not result in efficient integration into the host ICM (Tachibana et al. 2012) . Unlike mouse ICM chimeras, monkey donor and host ICMs develop into separate offspring while sharing the TE compartment of host blastocysts. Thus, whole ICM injection into a host blastocyst will often produce twin fetuses. Analysis of such rhesus fetuses demonstrated limited chimerism in their bodies (embryo proper; Tachibana et al. 2012) . Specifically, chimerism was only detected in livers and spleens that possibly could result from the exchange of blood and blood stem cells through placental perfusions. However, chimerism in the extraembryonic compartment consisting of chorionic and amniotic tissues was extensive, indicating that both the host embryo and injected ICMs contributed to these lineages.
To investigate possible mechanisms responsible for the inability of injected ICMs to incorporate with host ICMs and form embryo proper chimeras, monkey blastocysts and ICMs were analyzed for lineage segregation. Cells within an ICM in mouse preimplantation-stage (E3.5) blastocysts are relatively homogeneous and not visibly differentiated into epiblast and PE fates. Such segregation is apparent in peri-implantation blastocysts (E4.5), where the layer of the PE is spatially separated and covers underlying epiblast cells (Cockburn & Rossant 2010 ). This segregation coincides with a significant decline in the ability of host ICM to incorporate injected pluripotent cells and form mouse chimeras (Ohta et al. 2008) .
Analysis of preimplantation blastocysts has demonstrated that monkey ICMs have already segregated into the epiblast and PE lineages. Even in early blastocysts, ICMs consisted of a cluster of NANOG-positive epiblast that was covered by GATA6-positive PE cells. This event likely prevents efficient aggregation of injected ICMs or ESCs with donor ICMs and the formation of embryo proper chimeras.
In contrast to ICMs, monkey chimeras were efficiently produced by the aggregation of cleaving 4-cell embryos (Fig. 2) . It was demonstrated that blastomeres of the 4-cell monkey embryos are totipotent since a single blastomere can support full-term development (Chan et al. 2000) . Between three and six individual 4-cell monkey embryos were aggregated together and 14 resulting blastocysts were transplanted into five recipients (Tachibana et al. 2012) . Remarkably, all the five recipients became pregnant: two females carried singletons, another two carried twins, and one recipient had quadruplets. Such high pregnancy (100%) and implantation rates (10/14 or 71%) were remarkable, considering that average rhesus embryo transfer outcomes with nonchimeric embryos do not exceed 36% pregnancy and 17% implantation rates (Wolf et al. 2004) . Since chimeric blastocysts consisted of much higher cell counts (double or triple of regular numbers), (Tachibana et al. 2012) . Extensive contribution of parental embryos in the blood and extraembryonic tissues was confirmed using microsatellite and mtDNA genotyping. In addition, sex-specific PCR, G-banding, and fluorescent in situ hybridization (FISH)-based cytogenetic assays detected the presence of both male (XY) and female (XX) cells in Roku, suggesting sex chimerism.
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it is possible that sufficient cell numbers in preimplantation embryos are critical for pregnancy initiation.
When several midgestation rhesus fetuses were recovered and analyzed for the genetic contribution of parental embryos, all offspring were confirmed to be chimeras. Remarkably, chimerism was detected in all the tested tissues and organs including placenta, spleen, reproductive tract, bladder, pancreas, stomach, small intestine, adrenal gland, kidney, and muscle. Since chimeric embryos were generated by aggregating together of three or more cleaving embryos, some fetuses displayed the contribution of multiple parental genotypes. Chimerism was also confirmed in three live born infants that were phenotypically normal males (Fig. 2) . However, detailed cytogenetic analysis of blood showed that one infant contained both male (XY) and female (XX) cells, confirming sex chimerism.
ESCs in other species
Although derivation of ESCs or ESC-like cells expressing pluripotency markers has been reported for several species, only mouse and rat ESCs have so far been shown to contribute to germline chimeras. The first germline-competent rat ESCs were recently derived using modified culture conditions . These cells express typical pluripotency markers and retain the capacity to differentiate into derivatives of all the three germ layers. Most importantly, they efficiently induce chimeras when reintroduced into early-cleaving embryos . Rat ESCs were also capable of contributing to the germline and some extraembryonic lineages (Demers et al. 2011) .
It is currently assumed that species-specific differences in ESC maintenance and culture between mouse and farm animals are the posing factors challenging the identification and derivation of putative ESCs. As an example, enzymatic dissociation of cattle ESCs results in cell death or differentiation (Stice et al. 1996 , Cibelli et al. 1998 ). In addition, there is inconsistency among proposed markers for defining genuine bovine ESCs (Malaver-Ortega et al. 2012). It has been reported that livestock ESCs share some morphologic features with mouse EpiSCs rather than with mouse ESCs. These unique characteristics include flat epithelial-like cells that have low tolerance to enzymatic single-cell dissociation (Tesar et al. 2007) . Several studies have reported the isolation of bovine ESC-like cells that are capable of contributing to the somatic tissues in chimeric offspring (Saito et al. 1992 , Cibelli et al. 1998 . Putative ESCs were also described from porcine blastocysts and have been shown to contribute to some somatic tissues in chimeras (Wheeler 1994 , Chen et al. 1999 , Brevini et al. 2010 , Vassiliev et al. 2010 . There was no germline contribution of ESCs documented in these chimeras. Caprine and ovine embryo-derived cell lines have also been isolated, however pluripotency was not tested in chimeras (Notarianni et al. 1991 , Wells et al. 1997 , Dattena et al. 2006 , Pawar et al. 2009 , Behboodi et al. 2011 , Kumar De et al. 2011 .
Recent advances in iPSC technology have opened new opportunities for the generation of pluripotent stem cells from many species including rat ), rhesus monkey (Liu et al. 2008) , cattle (Han et al. 2011) , sheep (Liu et al. 2012) , and pig (Ezashi et al. 2009 , Wu et al. 2009 ). Porcine iPSCs were recently reported to induce chimeras contributing to multiple tissues that represented all the three germ layers (West et al. 2010) . Fujishiro et al. (2012) demonstrated the generation of naive-like porcine iPSCs also capable of contributing to a variety of organs in chimeric fetuses (head, branchial arch, atrium, ventricle, liver, and limb bud) . However, no germline contribution has been observed.
Chimerism in humans
Embryonic chimerism in humans generally occurs by the spontaneous aggregation of two different zygotes or embryos. Lacking the visible features of chimerism, the condition goes underdiagnosed in most cases. Therefore, reported cases of chimerism are generally those associated with either developmental anomalies or genotype/sex discordance (Boklage 2006) . One classic example of tetragametic chimerism was a woman waiting for organ donation from her biological children. However, the histocompatibility testing indicated that the children were of different genotypes. She was later confirmed to be a germline chimera producing two different germ cell populations (Yu et al. 2002) . Interestingly, she was phenotypically normal XX/XX chimera with no detectable chimerism in her peripheral blood.
Infertility treatments by IVF could potentially increase the risk of spontaneous tetragametic chimerism. Typically, improved pregnancy rates are achieved by placing more than one embryo into a patient. This can result in up to 30-to 35-fold increase in dizygotic twin deliveries. Multiple embryo transfers could also lead to the increased risk of chimerism (Strain et al. 1998) .
Human chimerism can also be caused by the aggregation of fertilized embryos with unfertilized parthenogenetic or androgenetic embryos or by aggregation with the fertilized second polar body (Strain et al. 1995 , Malan et al. 2006 .
The term 'microchimerism' (Mc) refers to a small population of donor cells in the body (fewer than 1 in 100 cells; Gammill & Nelson 2010 (Zeng et al. 2010 , Kara et al. 2012 .
Conclusions
Naturally occurring embryonic chimeras in mammals are rare; however, experimental induction of chimeric animals by mixing early embryonic cells has gained a lot of momentum and is currently being used in biomedical research for potency determination of various cell types. Mouse chimeras in particular with ESCs have become a revolutionary assay to study the gene function in knockout models. The chimera assay is the most rigorous and ultimate measure of pluripotency in experimental pluripotent cells derived by the reprogramming of somatic cells. Specifically, tetraploid chimeras are considered as the most comprehensive test, as it enables the production of whole stem cell-derived mouse offspring. Chimerism in humans is a much more common phenomenon than originally thought. Particularly, Mc resulting from mutual penetration of fetal and maternal cells is common in children and their mothers.
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